• Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
TheraCryf
  • Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
Mobile close button Mobile toggle button

AIM Admission Document

steve | 15 October 2015
Categories:

Post navigation

← Articles of Association
SFX-01 targets STAT3 signalling to inhibit stem-like cells in breast cancer patient-derived xenograft tumours, presented at the UK Interdisciplinary Breast Cancer Symposium 2018 →
footer logo
Copyright© 2025
ICO Reg: ZB396415
Company Number: 09246681
  • Website Privacy Policy and Cookie Policy
  • Sitemap
Twitter Twitter linkedin linkedin
Get in touch